GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (OSTO:ENZY) » Definitions » Earnings Yield (Joel Greenblatt) %

Enzymatica AB (OSTO:ENZY) Earnings Yield (Joel Greenblatt) % : -9.16% (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Enzymatica AB Earnings Yield (Joel Greenblatt) %?

Enzymatica AB's Enterprise Value for the quarter that ended in Mar. 2024 was kr564.57 Mil. Enzymatica AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr-51.69 Mil. Enzymatica AB's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2024 was -9.16%.

The historical rank and industry rank for Enzymatica AB's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

OSTO:ENZY' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -56.73   Med: -9.83   Max: -0.41
Current: -9.54

During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Enzymatica AB was -0.41%. The lowest was -56.73%. And the median was -9.83%.

OSTO:ENZY's Earnings Yield (Joel Greenblatt) % is ranked worse than
76.35% of 1095 companies
in the Drug Manufacturers industry
Industry Median: 2.25 vs OSTO:ENZY: -9.54

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Enzymatica AB's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2024 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Enzymatica AB Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Enzymatica AB's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB Earnings Yield (Joel Greenblatt) % Chart

Enzymatica AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.66 -0.46 -3.51 -9.53 -7.24

Enzymatica AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.23 -14.14 -9.79 -7.24 -9.16

Competitive Comparison of Enzymatica AB's Earnings Yield (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, Enzymatica AB's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzymatica AB's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzymatica AB's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Enzymatica AB's Earnings Yield (Joel Greenblatt) % falls into.



Enzymatica AB Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Enzymatica ABs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-47.631/657.705865
=-7.24 %

Enzymatica AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-51.69 Mil.



Enzymatica AB  (OSTO:ENZY) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Enzymatica AB Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Enzymatica AB's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzymatica AB (OSTO:ENZY) Business Description

Industry
Traded in Other Exchanges
Address
Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB (OSTO:ENZY) Headlines

From GuruFocus

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson 12-07-2015

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon 07-01-2016

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi 12-20-2016